公开(公告)号：US20180105509A1

公开(公告)日：2018-04-19

申请号：US15567668

申请日：2016-04-20

Applicant: ALMIRALL, S.A.

Inventor： James DUFFY ,  Mark Stuart CHAMBERS ,  Alastair RAE ,  James OSBORNE ,  Isabelle Anne LEMASSON ,  Michael Daniel GOLDSMITH ,  Andrew SHARPE ,  Silvia FONQUERNA POU

IPC: C07D401/12 ,  C07D231/38 ,  C07D249/06 ,  C07D401/14 ,  C07D403/10 ,  C07D403/12 ,  A61P25/02

CPC classification number: C07D401/12 ,  A61P25/02 ,  C07D231/38 ,  C07D249/06 ,  C07D249/14 ,  C07D401/04 ,  C07D401/14 ,  C07D403/06 ,  C07D403/10 ,  C07D403/12 ,  C07D405/12 ,  C07D405/14 ,  C07D413/14

Abstract: The present invention relates to novel aminoindazolyl derivative compounds of Formula (I), the use of said compounds in treating diseases mediated by modulation of voltage-gated sodium channels in particular Nav1.7 AND to compositions containing said derivatives.